Just in the previous years, researchers have recognized the big role that the microorganisms living inside and on us play in our health. The human microbiome, and specifically the gut microbiome, has been connected to multiple persistent diseases, including diabetes. An unbalanced microbiome composition has actually been found in clients with diabetes, who tend to have a less diverse gut microbiome as compared to healthy people. Price Features.
Some business are developing diabetes treatments targeting the microbiome. The French Valviotis is currently conducting preclinical screening of a drug targeted at increasing the microbiome diversity as a treatment for type 2 diabetes. Although promising, the microbiome field is very young and its complexity makes it hard to develop causation after finding connection.
That world might not be so far away, as lots of business are establishing non-invasive methods to replace finger pricking. Price Features. Integrity Applications has developed a device called GlucoTrack that can measure glucose utilizing electro-magnetic waves and is currently offered in Europe. Similar technologies are turning up, with GlucoSense in London utilizing laser light to determine sugar levels and MediWise making usage of radio waves.
The GlucoWise sensing unit prototypePatches are also becoming a popular type of measuring blood sugar without needles, such as FreeStyle Libre, an inch-wide spot that can be worn for approximately 2 weeks. At the University of Bath, researchers are establishing a graphene spot that might supply higher accuracy by determining sugar levels separately in multiple hair follicles – Price Features.
On the other hand, Senseonic and Roche are dealing with a gadget that is implanted under the skin. Price Features. Still, non-invasive choices to measure blood sugar level typically deal with concerns relating to precision. The popular glucose-measuring contact lens that Google revealed in 2014 was dismissed as “technically infeasible” and further developments will be needed to reach the degree of accuracy of finger-pricking methods.
Scientists are already hypothesizing about microchips that can identify diabetes type 1 before the symptoms appear or nanorobots traveling in the bloodstream while they measure glucose and deliver insulin – Price Features.”There’s little fiction left in this. I highly think that microrobotics will come and will belong to our drug delivery within the next ten years,” stated Tomas Landh, Director of Method and Innovation Sourcing at Novo Nordisk, at the 2013 Medicon Valley Alliance Annual MeetingWhatever the future brings, it will certainly make a big difference in the lives of countless individuals worldwide.